NDRC continues resale price maintenance crack-down
On 5 December 2016, the National Development and Reform Commission (“NDRC“) – one of the three Chinese antitrust authorities – issued its decision fining the local unit of Medtronic, a U.S.-listed medical device maker, for resale price maintenance (“RPM“). Case summary Medtronic was found to maintain a distribution system for cardiovascular, rehabilitation therapy and…